# HERON THERAPEUTICS, INC. /DE/ (HRTX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from HERON THERAPEUTICS, INC. /DE/'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/HRTX/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073515 (https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/HRTX/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-028374 (https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm)
- [FY 2023 MD&A](/company/HRTX/mda/fy2023/): filed 2024-03-12; accession 0000950170-24-029951 (https://www.sec.gov/Archives/edgar/data/818033/000095017024029951/hrtx-20231231.htm)
- [FY 2022 MD&A](/company/HRTX/mda/fy2022/): filed 2023-03-29; accession 0000950170-23-010603 (https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm)
- [FY 2021 MD&A](/company/HRTX/mda/fy2021/): filed 2022-02-28; accession 0001564590-22-007618 (https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm)

Back to /company/HRTX/